One of the most common birth defects in the world is hearing loss. Every 1,000 babies are born with permanent hearing loss in one or both ears. Hearing loss can have a significant impact on a baby's development.
CapitalBio created Hereditary #Deafness Gene Detection Item using semiconductor sequencing technology. It can identify #100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection is more than 99.9 percent accurate.
The Bioelectron gene sequencer 4000 platform was created in collaboration with Thermo Fisher. It can detect 384 samples at the same time.
Why Do You Need Chromosomal Microarray Analysis?April 4, 2023Chromosomes are genetic material and the carriers of genes. The human body has 23 pairs of chromosomes, with 22 pairs being common to both sexes and called autosomes. The other pair determines sex and...view
What Is Chromosome Karyotype Analysis?April 4, 2023Chromosome karyotype analysis is a technique that traditionally involves observing the morphology of chromosomes. In recent years, fluorescence in situ hybridization technology has been used to detect...view
In Vitro Diagnostic Design: What are LDT and IVD?April 4, 2023Medical professionals usually rely on various tools to diagnose conditions and guide treatment decisions. The most commonly used is in vitro diagnostics (IVD) technology. Patients may receive or decli...view
A Deep Dive into CapitalBio's LuxScan TechnologyFebruary 8, 2024Microarrays have revolutionized the field of life sciences, enabling researchers to analyze thousands of genes simultaneously. This technology underpins advancements in various fields, from drug disco...view
What Are the Clinical Presentations of Colorectal Cancer?April 4, 2023Colorectal cancer is a common malignant tumor, including colon cancer and rectal cancer. The incidence of colorectal cancer is highest in the rectum, followed by the sigmoid colon, cecum, ascending co...view